PPM1A facilitates both nuclear distribution and transcription potency of YAP/TAZ. by Ruyuan Zhou (10197187)

“…<b>(B–D)</b> Transcription potency of YAP (5 ng), which was suppressed by coexpression of MST1 (50 ng) (B), LATS1 (500 ng) (C), or MAP4K1 (50 ng) (D), was markedly recovered by cotransfection of wild-type PPM1A but not the enzyme-dead PPM1A (D239N). …”

Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity. by Nevena Grdović (394542)

Peak stress decreases following a ramp-stretch as the time of stretch (post-load clamp) increases, consistent with the twitch relaxation throughout diastole. by Bertrand C. W. Tanner (18098420)

Spontaneous oxycodone withdrawal initially flattens NREM power rhythms, decreases low frequency and increases high frequency power. by Michael Gulledge (20577135)

Compounds decrease polyQ toxicity in a <i>pqe-1</i> independent manner in aged animals. by Cindy Voisine (30589)

liver tissue, stained with Masson´s trichrome staine, of (a) normal rats showing scant faint blue-stained fibrous in the portal area, (b) TAA-treated group showing strong blue-stai... by Sally A. El Awdan (710176)

Forced activation of STAT1 causes a significant decrease in IFN-λ expression during IAV infection. by Haitao Wei (505384)

BH3 Peptides induces a decrease in mitochondrial membrane potential but does not engage the Permeability Transition Pore. by Emelyn H. Shroff (163459)

Elemental analysis (C, H, N and O by difference) results for the dried bio-oils from pyrolysis of pretreated banagrass as a function of temperature and vapor residence time. by Trevor James Morgan (787777)

Markedly decreased sensitivity of HIV entry to gp120 directed inhibitors during cell-cell transmission. by Irene A. Abela (173068)

Effect of cilostazol on liver content of cAMP in TAA-induced fibrosis in rats. by Sally A. El Awdan (710176)

MiR-20a overexpression decreases LIMK1 protein expression in thyroid cancer cell lines. by Yin Xiong (342546)

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC₅₀ concentration of fenretinide during different time points (24–48–72 hours). …”

Loss of CAV1 increases taxane sensitivity, by decreasing taxane turnover independent of loss of MDR1. by Seth A. Brodie (629842)

Expression of Aβ42 decreases K_v4 protein and currents in the intact brain. by Yong Ping (233004)

Hedgehog signaling is decreased in <i>Foxa1</i>;<i>Foxa2</i> double knockouts. by Jennifer A. Maier (278698)

“…At E9.5, <i>Shh</i> mRNA is found in the brain, midline, and hindgut of control (A) <i>Foxa1</i> null (B) and <i>Foxa2</i> knockout embryos (C). …”

M344 decreases orthotopic pancreatic tumor growth when used as a treatment alone or in combination with gemcitabine. by Shelby M. Knoche (13833807)

Pre-treatment with CDDO-Me decreases IR-induced DNA damage in a variety of non-cancerous cells. by Mariam El-Ashmawy (678638)

“…(A) HBEC 3KT, (B) HME1, and (C) PBMCs were treated with CDDO-Me 18 hours prior to IR, then mounted on slides 30 min post-IR. …”

Cellular uptake of [¹⁴C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA. by Takuro Iwao (14636741)

GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)